NIKYA WATSON: Open Payments
NPI 1932811304 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 20 payments from 9 companies in 2025. Trend: 2023 $893 · 2024 $611 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $136 |
| Exact Sciences Corporation | 4 | $87 |
| PFIZER INC. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $35 |
| ABBVIE INC. | 1 | $23 |
| Saluda Medical Americas, Inc. | 1 | $19 |
| Corcept Therapeutics | 1 | $19 |
| Phadia US Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: AIRSUPRA, The Cologuard Plus Collection Kit, ELIQUIS, LEQVIO, FARXIGA, QULIPTA, Cologuard Collection Kit, Evoke.
Industry payments across AZ — which companies pay providers there.
